The Arab Drug Company (EGX:ADCI)

The Arab Drug Company Ratios and Metrics

Market cap in millions EGP. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 21, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	2,761	482	401	275	397	354
Market Cap Growth	432.51%	20.27%	45.83%	-30.70%	12.18%	98.95%
Enterprise Value	3,190	766	505	302	355	305
Last Close Price	230.07	37.31	28.90	18.02	23.73	19.79
PE Ratio	17.39	5.46	5.64	3.61	3.91	3.81
Forward PE	-	8.58	8.58	8.58	8.58	8.58
PS Ratio	2.69	0.61	0.63	0.55	0.74	0.68
PB Ratio	4.93	1.05	1.05	0.81	1.28	1.42
P/TBV Ratio	4.93	1.05	1.05	0.81	1.28	1.42
P/FCF Ratio	100.84	-	16.49	-	51.48	5.00
P/OCF Ratio	17.78	3.55	4.58	8.37	10.85	4.83
EV/Sales Ratio	3.11	0.98	0.80	0.60	0.66	0.59
EV/EBITDA Ratio	11.50	5.98	5.08	3.01	2.73	2.59
EV/EBIT Ratio	12.71	6.48	5.21	3.32	2.90	2.60
EV/FCF Ratio	116.52	-	20.77	-	46.03	4.32
Debt / Equity Ratio	0.95	1.13	0.50	0.44	0.07	0.06
Debt / EBITDA Ratio	1.91	4.01	1.91	1.51	0.16	0.12
Debt / FCF Ratio	19.33	-	7.90	-	2.75	0.20
Asset Turnover	0.87	0.87	1.01	0.99	1.31	1.55
Inventory Turnover	2.21	2.12	1.71	1.61	1.85	2.08
Quick Ratio	0.72	1.01	0.73	0.68	0.80	0.76
Current Ratio	1.51	1.93	2.49	2.31	2.75	2.64
Return on Equity (ROE)	36.91%	24.43%	22.88%	23.48%	36.32%	42.35%
Return on Assets (ROA)	13.26%	8.13%	9.66%	11.12%	18.67%	21.87%
Return on Capital (ROIC)	15.25%	9.52%	11.38%	13.80%	25.73%	31.14%
Return on Capital Employed (ROCE)	30.50%	15.00%	19.80%	23.10%	39.50%	47.10%
Earnings Yield	5.75%	21.32%	20.64%	27.74%	25.55%	26.23%
FCF Yield	0.99%	-17.24%	6.07%	-20.74%	1.94%	19.98%
Dividend Yield	1.81%	11.19%	7.79%	13.32%	10.54%	6.32%
Payout Ratio	32.23%	35.11%	45.29%	57.06%	38.31%	34.69%
Buyback Yield / Dilution	-12.16%	-	11.45%	2.11%	6.76%	6.65%
Total Shareholder Return	-10.35%	11.19%	19.24%	15.43%	17.29%	12.96%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.